A new cancer vaccine, based on genetically modified bacteria, was developed by a team of scientists at Columbia University.
Researchers have worked to harness the power of bacteria in an unusual way, only in tests on mice with colon cancer and melanoma, but with highly positive results.
The…
Read More...
